Your browser is no longer supported. Please, upgrade your browser.
CELC Celcuity Inc. monthly Stock Chart
CELC [NASD]
Celcuity Inc.
Index- P/E- EPS (ttm)-0.85 Insider Own39.00% Shs Outstand10.27M Perf Week10.63%
Market Cap103.35M Forward P/E- EPS next Y-1.06 Insider Trans0.00% Shs Float5.03M Perf Month79.82%
Income-8.70M PEG- EPS next Q-0.22 Inst Own18.60% Short Float0.42% Perf Quarter74.73%
Sales- P/S- EPS this Y2.60% Inst Trans-8.09% Short Ratio2.81 Perf Half Y-7.14%
Book/sh1.34 P/B7.38 EPS next Y-37.70% ROA-49.70% Target Price13.50 Perf Year-1.00%
Cash/sh- P/C- EPS next 5Y14.00% ROE-52.60% 52W Range4.03 - 12.70 Perf YTD-7.05%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-22.13% Beta-
Dividend %- Quick Ratio13.50 Sales past 5Y- Gross Margin- 52W Low145.41% ATR0.65
Employees27 Current Ratio13.50 Sales Q/Q- Oper. Margin- RSI (14)75.99 Volatility7.79% 9.90%
OptionableNo Debt/Eq0.00 EPS Q/Q-24.30% Profit Margin- Rel Volume2.49 Prev Close9.35
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume7.55K Price9.89
Recom2.00 SMA2034.49% SMA5056.46% SMA20048.20% Volume18,798 Change5.78%
May-11-20Resumed Craig Hallum Buy
Nov-20-18Initiated H.C. Wainwright Buy $36
Nov-09-20 04:00PM  
02:30PM  
Oct-26-20 03:15PM  
Oct-04-20 09:30AM  
09:30AM  
Aug-27-20 09:45AM  
Aug-10-20 04:00PM  
Jul-24-20 04:45PM  
Jul-01-20 05:30PM  
Jun-22-20 07:00PM  
May-07-20 04:00PM  
Apr-23-20 04:40PM  
Apr-07-20 09:23AM  
Mar-12-20 04:00PM  
02:30PM  
Feb-27-20 04:15PM  
Dec-12-19 11:07AM  
Dec-11-19 07:25PM  
08:34AM  
Dec-05-19 10:24AM  
Nov-07-19 04:01PM  
Nov-01-19 09:00AM  
Oct-28-19 11:28AM  
Oct-24-19 03:31PM  
Sep-24-19 08:50AM  
Sep-11-19 11:37AM  
Sep-10-19 09:01AM  
07:59AM  
Sep-09-19 09:37AM  
Aug-19-19 05:55PM  
09:00AM  
Aug-08-19 04:00PM  
Jul-25-19 03:34PM  
Jun-27-19 09:00AM  
May-20-19 02:36PM  
May-13-19 09:00AM  
May-07-19 04:01PM  
02:30PM  
Apr-29-19 10:50AM  
Apr-23-19 01:48PM  
Apr-12-19 08:50AM  
Apr-10-19 08:45AM  
Apr-04-19 08:33AM  
Mar-07-19 08:58AM  
Mar-05-19 08:48AM  
Feb-26-19 09:20PM  
04:01PM  
Feb-14-19 05:12PM  
Dec-25-18 03:00PM  
Dec-11-18 08:10AM  
Dec-07-18 06:33PM  
Nov-13-18 04:00PM  
Oct-31-18 08:00AM  
Oct-30-18 04:56PM  
Oct-19-18 07:45AM  
Oct-16-18 05:51PM  
Aug-09-18 04:00PM  
02:30PM  
Aug-02-18 04:31PM  
May-14-18 04:00PM  
May-02-18 12:28PM  
Mar-19-18 07:33AM  
Mar-15-18 04:00PM  
Mar-02-18 04:00PM  
Jan-19-18 07:30AM  
Nov-13-17 07:00AM  
Nov-02-17 01:08PM  
Oct-31-17 09:15PM  
Sep-24-17 09:57AM  
Sep-22-17 04:05PM  
Sep-20-17 06:00AM  
Celcuity Inc., a clinical stage biotechnology company, discovers cancer sub-types and therapeutic options for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. It develops CELsignia HSF test to diagnose two new sub-types of HER2-negative breast cancer. The company is also developing CELsignia MP test to diagnose 11 cancer sub-types in breast, lung, colon, ovarian, kidney, and bladder cancers. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.